An entire story about BioPharma corporate R&D gap funds (with no mention of universities)

I couldn’t believe it either. A really good article released from GEN (Genetic Engineering and Biotechnology News) underscores an emerging trend in pharma pre-seed gap funding investment in R&D as an answer  to a retraction of early stage VC from biotech and pharma sectors. One issue, how can you have a conversation about “Drugs” +”R&D”+”external partnerships” […]